Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
A Phase II Multiple-Dose, Multiple-Arm, Parallel Assignment Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of XmAb20717 Alone or in Combination with Chemotherapy or Targeted Therapies in Selected Subjects with Metastatic Castration-Resistant Prostate Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study Of Darolutamide Plus Androgen Deprivation Therapy ADT Compared To Placebo Plus ADT In Patients With High-Risk Biochemical Recurrence BCR Of Prostate Cancer
ARACOG: A Randomized Phase II Study of Androgen Receptor Directed Therapy on COGnitive Function in Patients Treated with Darolutamide or Enzalutamide
Study Type: Treatment
Phase: II
NCTID: NCT04335682
Principal Investigator:
Elizabeth Wulff-Burchfield
Cabazitaxel with Abiraterone versus Abiraterone Alone Randomized Trial for Extensive Disease Following Docetaxel: The CHAARTED2 Trial
A Prospective Comparative Study of Outcomes with Proton and Photon Radiation in Prostate Cancer COMPPARE
Effectiveness of the SpaceOAR Vue System in Subjects with Prostate Cancer being Treated with Stereotactic Body Radiotherapy SABRE
Study Type: Prevention
Phase: N/A
NCTID: NCT04905069
Principal Investigator:
Ronald Chen
An International, Prospective, Open-label, Multi-center, Randomized Phase III Study comparing lutetium 177Lu vipivotide tetraxetan AAA617 versus Observation to delay castration or disease recurrence in adult male patients with prostate-specific membrane antigen PSMA positive Oligometastatic Prostate Cancer OMPC
Study Type: Treatment
Phase: III
NCTID: NCT05939414
Principal Investigator:
Xinglei Shen
Weight management Aimed to Reduce Risk and Improve Outcomes from Radical Prostatectomy: WARRIOR
Study Type: Basic Science
Phase: N/A
NCTID: NCT03261271
Principal Investigator:
Jill Hamilton-Reeves
Prospective Validation of Prostate Biomarkers for Repeat Biopsy: The PRIORITY Study
Pilot Trial of Ultra-Hypofractionated Radiation in Early Prostate Cancer
Study Type: Treatment
Phase: Feasibility/Pilot
NCTID: NCT03486821
Principal Investigator:
Xinglei Shen